title: Patterns of care for lung cancer in radiation oncology departments of Turkey.
abstract: OBJECTIVE
  To determine the patterns of care for lung cancer in Turkish radiation oncology centers.
  
  
  METHODS
  Questionnaire forms from 21 of 24 (87.5%) centers that responded were evaluated.
  
  
  RESULTS
  The most frequent histology was non-small cell lung cancer (NSCLC) (81%). The most common postoperative radiotherapy (RT) indications were close/(+) surgical margins (95%) and presence of pN2 disease (91%). The most common indications for postoperative chemotherapy (CHT) were ">/= IB" disease (19%) and the presence of pN2 disease (19%). In Stage IIIA potentially resectable NSCLC, the most frequent treatment approach was neoadjuvant concomitant chemoradiotherapy (CHRT) (57%). In Stage IIIA unresectable and Stage IIIB disease, the most frequent approach was definitive concomitant CHRT (91%). In limited SCLC, the most common treatment approach was concomitant CHRT with cisplatin+etoposide for cycles 1-3, completion of CHT to cycles 4-6, and finally prophylactic cranial irradiation in patients with complete response (71%). Six cycles of cisplatin + etoposide CHT and palliative thoracic RT, when required, was the most commonly used treatment (81%) in extensive SCLC. Sixty-two percent of centers did not have endobronchial brachytherapy (EBB) facilities.
  
  
  CONCLUSIONS
  There is great variation in diagnostic testing, treatment strategies, indications for postoperative RT and CHT, RT features, and EBB availability for LC cases. To establish standards, national guidelines should be prepared using a multidisciplinary approach.
authors: Dokuz Eylul University Medical School, Department of Radiation Oncology, Izmir, Turkey.
authors: Ayşe Nur
authors: AN
authors: Demiral
authors: Zümre Arican
authors: ZA
authors: Alicikus
authors: Vahide
authors: V
authors: Işil Ugur
authors: Ilker
authors: I
authors: Karadogan
authors: Adnan
authors: A
authors: Yöney
authors: Meltem Nalça
authors: MN
authors: Andrieu
authors: Deniz
authors: D
authors: Yalman
authors: Yücel
authors: Y
authors: Pak
authors: Gamze
authors: G
authors: Aksu
authors: Gökhan
authors: G
authors: Ozyigit
authors: Lütfi
authors: L
authors: Ozkan
authors: Sevil
authors: S
authors: Kilçiksiz
authors: Sedat
authors: S
authors: Koca
authors: Murat
authors: M
authors: Caloğlu
authors: Ali Aydin
authors: AA
authors: Yavuz
authors: Hale
authors: H
authors: Başak Cağlar
authors: Murat
authors: M
authors: Beyzadeoğlu
authors: Sefik
authors: S
authors: Iğdem
authors: Meltem
authors: M
authors: Serin
authors: Bünyamin
authors: B
authors: Kaplan
authors: Mehmet
authors: M
authors: Koç
authors: Esra
authors: E
authors: Korkmaz
authors: Omür
authors: O
authors: Karakoyun-Celik
authors: Selvi
authors: S
authors: Dinçer
authors: Münir
authors: M
authors: Kinay
mesh_terms: D001918:Brachytherapy / Q000706:statistics & numerical data; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D009367:Neoplasm Staging; D005791:Patient Care / Q000379:methods* / Q000706:statistics & numerical data; D018787:Radiation Oncology / Q000458:organization & administration / Q000706:statistics & numerical data; D011879:Radiotherapy Dosage; D018570:Risk Assessment; D055752:Small Cell Lung Carcinoma / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D011795:Surveys and Questionnaires; D014421:Turkey; D000078329:Workforce